Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Revenue

Can-Fite BioPharma had revenue of $158.00K in the quarter ending June 30, 2024, a decrease of -19.39%. This brings the company's revenue in the last twelve months to $667.00K, down -15.89% year-over-year. In the year 2023, Can-Fite BioPharma had annual revenue of $743.00K, down -8.27%.

• Revenue (ttm): $667.00K
• Revenue Growth: -15.89%
• P/S Ratio: 23.17
• Revenue / Employee: $83,375
• Employees: 8
• Market Cap: 15.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	743.00K	-67.00K	-8.27%
Dec 31, 2022	810.00K	-43.00K	-5.04%
Dec 31, 2021	853.00K	90.00K	11.80%
Dec 31, 2020	763.00K	-1.27M	-62.45%
Dec 31, 2019	2.03M	-1.79M	-46.81%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.